Figure 3.
illustrates active lever responding in each drug/dose condition during the nACh Receptor Antagonist Challenge Tests. * indicates that 0.5 and 1 mg/kg mecamylamine pretreatment significantly reduced responding for the NIC group, ps<0.05.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.